3 Dec 2024

MASLD/MASH: Clinical and Economic Findings from 40-year Follow-Up Data

2024-12-04T16:34:27+01:00December 3, 2024|All, Other|

πŒπ€π’π‹πƒ/πŒπ€π’π‡: 𝐂π₯𝐒𝐧𝐒𝐜𝐚π₯ 𝐚𝐧𝐝 π„πœπ¨π§π¨π¦π’πœ 𝐅𝐒𝐧𝐝𝐒𝐧𝐠𝐬 𝐟𝐫𝐨𝐦 40-𝐲𝐞𝐚𝐫 𝐅𝐨π₯π₯𝐨𝐰-𝐔𝐩 πƒπšπ­πš
On Tuesday December 10th, Quantify’s Emilie Toresson Grip is one of three speakers at ISPOR’s webinar on MASLD/ MASH following their BRIDGE-MASH study.

Moderated by Riku Ota, Global Payer Evidence Lead at […]

2 Oct 2024

Nordic RWE in FDA decision making

2024-10-02T15:54:31+02:00October 2, 2024|All, Other|

The use of Real-World Data (RWD) to support regulatory decisions is growing rapidly.
Several regulating agencies have in the past few years issued guidelines on the requirements on Real-World Evidence (RWE)-studies to be fit-for purpose for regulatory purposes.

Nordic data properties share […]

1 Oct 2024

COHERE Finland!

2024-10-02T15:59:02+02:00October 1, 2024|Other|

On September 17th, Quantify Finland participated in the Council for Choices in Health Care in Finland (COHERE Finland)10th anniversary seminar. The theme of the seminar was β€œPrioritization and the service portfolio in 2030.”
The day featured several thought-provoking presentations with highlights […]

Go to Top